NCT03588091 2025-08-22Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast CancerJiangsu HengRui Medicine Co., Ltd.Phase 3 Completed355 enrolled
NCT04756921 2021-02-1618F-FDG Uptake Heterogeneity Predicts Pyrotinib ResponseFudan UniversityCompleted30 enrolled